Perillyl Alcohol in Treating Patients With Metastatic Breast Cancer
Status:
Completed
Trial end date:
1998-05-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of perillyl alcohol in treating patients
with metastatic breast cancer that has not responded to previous chemotherapy.